Linezolid Disposition during Peritonitis: A Case Report

Keane W.F. , Bailie G.R. , Boeschoten E. , Gokal R. , Golper T.A. , Holmes C.J. Adult peritoneal dialysis-related peritonitis treatment recommendations: 2000 update [Published erratum appears in Perit Dial Int 2000; 20: 828-9]. Perit Dial Int 2000; 20: 396–411.

Berns J.S. Infection with antimicrobial-resistant micro-organisms in dialysis patients. Semin Dial 2003; 16: 30–7.

Staphylococcus aureus resistant to vancomycin–United States 2002. MMWR Morb Mortal Wkly Rep 2002; 51: 565–7.

Vancomycin-resistant Staphylococcus aureus– Pennsylvania 2002 [Published erratum appears in MMWR Morb Mortal Wkly Rep 2002; 51: 931]. MMWR Morb Mortal Wkly Rep 2002; 51: 902.

Linezolid [package insert]. Peapack, NJ: Pharmacia & Upjohn; 2002.

Synercid [package insert]. Bridgewater, NJ: Aventis Pharmaceuticals; 2002.

Manley H.J. , McClaran M.L. , Bedenbaugh A. , Peolquin C.A. Linezolid stability in peritoneal dialysis solutions. Perit Dial Int 2002; 22: 419–22.

Bailey E.M. , Faber M.D. , Nafziger D.A. Linezolid for treatment of vancomycin resistant enterococcal peritonitis. Am J Kidney Dis 2001; 38: E20.

Gendjar S.R. , Moriyama B. , Bailey E.M. , Faber M. , Shetty A. , Borg D.L. Pharmacokinetics of oral linezolid in patients on peritoneal dialysis [Abstract]. J Am Soc Nephrol 2001; 12: A2205.

National Committee for Clinical Laboratory Standards. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically. 4th ed. Villanova, PA: National Committee for Clinical Laboratory Standards; 1997: approved standard, M7-A4.

Bernstein W.B. , Trotta R.F. , Rector J.T. , Tjaden J.A. , Barile A.J. Mechanisms for linezolid-induced anemia and thrombocytopenia. Ann Pharmacother 2003; 37: 517–20.